The Centre hospitalier universitaire Sainte-Justine is the largest mother and child centre in Canada and one of the four most important pediatric centres in North America. It is affiliated with the Université de Montréal, located in Montreal, Quebec, Canada.

During the past decade, Centre Hospitalier Universitaire Sainte-Justine conducted 257 clinical trials. In the 10-year time frame, 257 clinical trials started and 131 clinical trials were completed, i.e. on average, 51% percent of trials that started reached the finish line to date. In the past 5 years, 104 clinical trials started and 63 clinical trials were completed. i.e. 60.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Universitaire Sainte-Justine" #1 sponsor was "Children's Oncology Group" with 152 trials, followed by "St. Justine's Hospital" with 96 trials sponsored, "National Cancer Institute (NCI)" with 52 trials sponsored, "The Hospital for Sick Children" with 17 trials sponsored and "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 17 trials sponsored. Other sponsors include 228 different institutions and companies that sponsored additional 145 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Universitaire Sainte-Justine" #1 collaborator was "National Cancer Institute (NCI)" with 163 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 31 trials as a collaborator, "St. Justine's Hospital" with 23 trials as a collaborator, "The Hospital for Sick Children" with 12 trials as a collaborator and "Children's Hospital of Eastern Ontario" with 9 trials as a collaborator. Other collaborators include 428 different institutions and companies that were collaborators in the rest 275 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Universitaire Sainte-Justine" are "Leukemia" (33 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (24 trials), "Sarcoma" (21 trials), "Neuroblastoma" (19 trials) and "Lymphoma" (18 trials). Many other conditions were trialed in "Centre Hospitalier Universitaire Sainte-Justine" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Universitaire Sainte-Justine" are "Drug" (341 trials), "Other" (162 trials), "Biological" (112 trials), "Procedure" (87 trials) and "Radiation" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Placebo" (43 trials), "Cyclophosphamide" (38 trials), "cyclophosphamide" (38 trials) and "etoposide" (38 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Universitaire Sainte-Justine" are 523 trials for "All" genders, 26 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 182 active trials in "Centre Hospitalier Universitaire Sainte-Justine". 3 are not yet recruiting, 101 are recruiting, 70 are Active, not recruiting, and 8 are Enrolling by invitation. In total, there were 322 completed trials in Centre Hospitalier Universitaire Sainte-Justine, 2 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Universitaire Sainte-Justine, 71 "Phase 1" clinical trials were conducted, 159 "Phase 2" clinical trials and 163 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 86 trials that are defined as “Not Applicable".

Centre Hospitalier Universitaire Sainte-Justine has several departments that took part in Clinical trials: "CHU Sainte-Justine, Dept Neonatology" - 2 trials